GMT20260423 013418 Recording 1920x1200

Introduction to Allergic Rhinitis

Overview of the Class

• The session begins with a greeting and an introduction to the topic of allergic rhinitis, emphasizing its prevalence in outpatient consultations.

Understanding Allergic Rhinitis

• Allergic rhinitis is described as a pathological process frequently encountered in clinical practice due to nasal mucosa exposure to environmental allergens and pollutants.

Immunological Mechanisms Involved

Immune Response

• The discussion highlights the involvement of various T-cell types (TH1, TH2) in allergic rhinitis, focusing on the TH2 response that mediates inflammation in nasal mucosa.

Phases of Allergic Rhinitis

Early Phase Reaction

• The early phase occurs upon initial allergen exposure, leading to immune system sensitization through antigen-presenting cells that activate T lymphocytes.

Late Phase Reaction

• The late phase develops hours after allergen exposure, characterized by inflammatory cell infiltration (eosinophils, basophils), perpetuating symptoms through cytokine release.

Classification of Allergic Rhinitis

Types and Severity

• Allergic rhinitis is classified into intermittent (seasonal) and persistent forms; severity ranges from mild (minimal impact on daily activities) to moderate/severe (significant disruption).

Clinical Presentation

Symptoms and Triggers

• Symptoms typically begin in childhood or adolescence and are triggered by specific allergens such as pollen for seasonal rhinitis or dust mites for perennial rhinitis.

Characteristic Symptoms

• Key symptoms include:

• Sneezing fits due to histamine stimulation.

• Nasal obstruction from mucosal congestion.

• Profuse rhinorrhea (watery discharge).

• Itchy nose often leading to characteristic nasal manipulation known as "allergic salute."

Physical Examination Findings

Observations During Assessment

• Physical examination reveals pale turbinates with increased volume and clear mucus secretion; signs may also indicate secondary conditions like otitis media or chronic pharyngitis.

Diagnostic Tests for Allergic Rhinitis

Common Testing Methods

• Skin prick tests are commonly used for diagnosing allergies with high specificity; alternative tests include measuring serum IgE levels when skin tests are inconclusive.

Treatment Approaches

Comprehensive Management Strategies

• Effective management requires collaboration with families, combining medical treatment (e.g., corticosteroids, antihistamines) with environmental control measures to reduce allergen exposure at home.

Considerations for Asthmatic Patients

• Emphasis on recognizing that patients with asthma often have concurrent allergic rhinitis; thus, managing both conditions is crucial for overall health improvement.

Medical Treatment for Allergic Rhinitis

Initial Treatment Options

• Antihistamines are the first line of treatment for mild rhinitis, with options including loratadine and fexofenadine, which are effective without causing drowsiness.

• Cetirizine is also a good option but may cause somnolence; it is recommended for pediatric patients starting from age 6.

Age-Specific Recommendations

• For children aged 2 to 5 years, loratadine or fexofenadine can be used, while those over 12 have a wider range of antihistamine options available.

Additional Treatments

• Nasal corticosteroids such as fluticasone and mometasone are recommended alongside antihistamines for better management of symptoms.

• Oral decongestants can be used sporadically in conjunction with cetirizine or other antihistamines based on the patient's condition.

Long-Term Management Strategies

• Topical treatments like oxymetazoline should not exceed five days to avoid damaging nasal mucosa; long-term use requires careful monitoring.

• Corticosteroid nasal sprays take time to reach effectiveness, typically around 15 days of daily use, and should ideally be started alongside an antihistamine.

Treatment Duration and Efficacy

Recommended Treatment Duration

• A minimum of 90 days of continuous daily use is suggested for nasal corticosteroids to assess their efficacy properly.

Severity-Based Treatment Approaches

• Mild intermittent rhinitis can often be managed effectively with oral antihistamines alone; moderate to severe cases may require topical corticosteroids as well.

• Persistent mild cases might start with both antihistamines and corticosteroids, while more severe persistent cases could necessitate oral corticosteroids or intramuscular betamethasone for relief.

Immunotherapy Considerations

Indications for Immunotherapy

• Immunotherapy is indicated when there’s inadequate control through environmental management and pharmacotherapy or poor response to existing treatments. It aims at long-term symptom reduction and prevention against new allergens.

Benefits of Immunotherapy

• This treatment alters the natural progression of allergic rhinitis and can reduce asthma attacks due to the interconnected nature of asthma and allergic conditions.

Transitioning Topics: Peritonsillar Abscess

Introduction to Peritonsillar Abscess Anatomy

• The discussion shifts towards peritonsillar abscesses, focusing on anatomical structures such as the nasopharynx, oropharynx, and hypopharynx relevant in understanding this condition's development.

Understanding Peritonsillar Abscess Formation

Causes and Symptoms

• Peritonsillar abscesses often arise from chronic tonsillitis episodes leading to localized infections between the tonsil capsule and surrounding muscles; they present primarily unilaterally in adolescents with significant pain symptoms including odynophagia (painful swallowing).

Clinical Presentation

• Patients may exhibit trismus (difficulty opening mouth), halitosis (bad breath), fever due to septicemia, along with potential torticollis (neck stiffness). Examination reveals asymmetrical tonsils indicative of swelling on one side due to pus accumulation within the abscess cavity.

Clinical Insights on Peritonsillar Abscess and Epistaxis

Understanding Peritonsillar Abscess

• Observations include swelling of the tonsil, displacement of the uvula, and a white coating on the tongue indicative of peritonsillar abscess.

• Diagnosis relies heavily on clinical presentation; leukocytosis is confirmed through a hemogram showing increased polymorphonuclear cells.

• Aspiration is not recommended; instead, drainage should be performed with culture sent for analysis.

• Imaging such as CT scans can help assess abscess extent; palpation determines if it is fluctuating to guide treatment decisions.

• Incisions are left open to facilitate ongoing drainage alongside medical treatment.

Differential Diagnosis Considerations

• Differential diagnoses include allergic edema without fever, carotid artery aneurysms (pulsatile), and distant infections like tuberculosis.

Treatment Protocol for Peritonsillar Abscess

• In cases with significant purulent secretion, intravenous antibiotics like ceftriaxone combined with dexamethasone are preferred.

• If fluctuation is noted during examination, drainage may occur in an outpatient setting or under surgical conditions for children.

• Frequent episodes (three to four annually with leukocytosis) may warrant surgical intervention such as tonsillectomy after a period of observation.

Introduction to Epistaxis Management

• Transitioning to epistaxis management, highlighting its prevalence in emergency settings during internships.

Anatomy and Etiology of Nasal Bleeding

• The nasal mucosa's thin structure adheres closely to cartilage and has rich vascularization prone to bleeding.

• Key arterial supply includes branches from both internal and external carotids; common sites for anterior bleeding are identified as the Kiesselbach plexus.

Classification and Prevalence of Epistaxis

• Approximately 60% of individuals experience epistaxis at some point; 70% self-resolve. Most common in children and older adults.

Types of Epistaxis

• Anterior: Accounts for 90–95% of cases; typically mild-moderate bleeding observed easily in children/adolescents.

• Posterior: Less frequent (5–10%), often severe, requiring further investigation due to difficulty locating the source.

Local vs General Causes

• Local Causes: Trauma from nose-picking, rhinitis-related inflammation leading to bleeding, foreign bodies, or tumors.

• General Causes: Hematological disorders or systemic issues like hypertension or diabetes that predispose patients to nasal bleeding.

Diagnostic Approach

• Initial assessment involves determining bleed intensity and location (anterior/posterior).

• History-taking focuses on previous hemorrhages, medications (e.g., anticoagulants), family history of nasal bleeds.

This structured approach provides clarity on managing peritonsillar abscesses and epistaxis while emphasizing critical diagnostic considerations and treatment protocols.

Management of Nasal Hemorrhage (Epistaxis)

Initial Assessment and Treatment Options

• If no bleeding point is identified, a nasal endoscopy is performed to locate the source behind the inferior turbinate and at the S point.

• For mild anterior hemorrhages, conservative treatment may include cauterization; for severe cases, airway management and either anterior or posterior packing are necessary.

Immediate Care Techniques

• In cases of non-profuse bleeding, tilting the head downwards while applying pressure for 5 minutes can help stop the bleeding. Tilting backward may cause blood to flow down the throat, leading to irritation and potential vomiting.

Cauterization Procedures

• If a bleeding point is visible during consultation and the patient isn't congested, chemical cauterization with silver nitrate or electrocautery for larger varices may be considered.

• If cauterization fails or if the bleeding point remains unidentified after anterior packing, posterior packing should be attempted.

Packing Techniques

• Anterior nasal packing involves using a moist gauze soaked in lidocaine with epinephrine or other agents. The gauze should fill both nasal cavities adequately.

• The technique includes inserting gauze in an S-shape from back to front or vice versa to ensure complete coverage of both nostrils.

Follow-Up Care and Considerations

• Ideally, nasal packing (anterior or posterior) should remain in place for about 5 days. Antihistamines and antibiotics are also prescribed to prevent complications like vestibulitis or sinusitis.

Understanding Epistaxis Types

Differentiating Anterior vs. Posterior Epistaxis

• Anterior epistaxis typically involves the Kiesselbach plexus located in the anterior third of the nasal septum; treatment options include chemical cauterization or anterior packing.

• Posterior epistaxis focuses on locating sources via nasal endoscopy targeting areas like Gutfreund's plexus; treatments may involve more complex procedures including anteroposterior packing.

Immunotherapy Discussion

Patient Management Strategies

• Immunotherapy decisions depend on patient history; those with rhinitis who have not responded well to antihistamines and topical corticosteroids might be referred to an immunologist for further evaluation.

Treatment Duration

• Immunotherapy typically requires annual commitment; patients must understand this long-term approach when considering their treatment options.